Filed for Regulatory Approval of Mitapivat (PYRUKYND®) for the Treatment of Adult Patients with Non-Transfusion-Dependent and ...
Telix Pharmaceuticals Limited (ASX: TLX, Nasdaq: TLX, Telix, the Company) today announces presentations featuring the Company ...
Blueprint Medicines Corporation (NASDAQ: BPMC) today reported financial results and provided a business update for the fourth ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback